BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 9934349)

  • 1. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?
    Bunting PS
    Clin Biochem; 2004 Oct; 37(10):898-903. PubMed ID: 15369721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
    Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSA testing in general practice.
    Little B; Ho KJ; Gormley G; Young M
    Prostate Cancer Prostatic Dis; 2003; 6(2):154-8. PubMed ID: 12806375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for prostate cancer: a comparison of urologists and primary care physicians.
    McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
    South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of PSA requests from general practitioners received by one Dublin hospital.
    McGing PG
    Ir Med J; 1998; 91(2):61-2. PubMed ID: 9617033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice patterns in screening and management of prostate cancer in elderly men.
    Konety BR; Sharp VJ; Verma M; Williams RD;
    Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic prostate-specific antigen screening in Italy: 6 years of monitoring from the Italian general practice database.
    D'Ambrosio GG; Campo S; Cancian M; Pecchioli S; Mazzaglia G
    Eur J Cancer Prev; 2010 Nov; 19(6):413-6. PubMed ID: 20679895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes and practices of primary care physicians for prostate cancer screening.
    Hoffman RM; Papenfuss MR; Buller DB; Moon TE
    Am J Prev Med; 1996; 12(4):277-81. PubMed ID: 8874692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dissemination of evidence-based information about PSA test and prostatic cancer to physicians].
    Norderhaug IN; Wisløff T; Fosså S; Sandberg S; Malde K; Forland F; Førde OH
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2893-5. PubMed ID: 15550959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.
    Haggerty J; Tudiver F; Brown JB; Herbert C; Ciampi A; Guibert R
    Can Fam Physician; 2005 Dec; 51(12):1658-9. PubMed ID: 16926946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific patterns of prostate-specific antigen testing among primary care physician visits.
    McNaughton Collins M; Stafford RS; Barry MJ
    J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
    Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
    Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting?
    Tudiver F; Guibert R; Haggerty J; Ciampi A; Medved W; Brown JB; Herbert C; Katz A; Ritvo P; Grant B; Goel V; Smith P; O'Beirne M; Williams JI; Moliner P
    J Fam Pract; 2002 Sep; 51(9):760. PubMed ID: 12366894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician clinical experience and inappropriate prostate specific antigen screening: evidence from an Asian country.
    Kuo NW; Lin HC; Lee HC
    J Urol; 2008 Nov; 180(5):1954-8; discussion 1958. PubMed ID: 18801533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for prostate cancer: what do general practitioners think?
    Morris J; McNoe B
    N Z Med J; 1997 May; 110(1044):178-82. PubMed ID: 9201202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen testing in men older than 75 years in the United States.
    Scales CD; Curtis LH; Norris RD; Schulman KA; Albala DM; Moul JW
    J Urol; 2006 Aug; 176(2):511-4. PubMed ID: 16813879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of the prostate cancer. "lnstantaneous" of a daily practice among 300 general practitioners of the canton of Vaud].
    Praz V; Jichlinski P; Aymon D; Leisinger HJ
    Rev Med Suisse; 2005 Dec; 1(44):2840-2. PubMed ID: 16382715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.